Crimson Life Sciences Offers Cost-Saving Technology Solution for Chinese Regulation 276
11/5/2012 10:11:43 AM
More...
|
First Patent for Translation Risk Management Awarded to Crimson Life Sciences
4/18/2012 9:53:50 AM
More...
|
Crimson Life Sciences Release: In-Vitro Diagnostics (IVD) Manufacturers at Risk for Device Reclassification
3/20/2012 7:11:12 AM
More...
|
Crimson Life Sciences Release: Expert Opinion Webcast Reveals $400 Million Potential Savings for Medical Device Industry
2/14/2012 8:02:37 AM
More...
|
Crimson Life Sciences Release: U.S. Medical Device “Total Cost of Content” Estimated at over $1 Billion
10/18/2011 10:23:44 AM
More...
|
Crimson Life Sciences Launches Japan Digest to Provide Market Insight for U.S. Medical Device Manufacturers
8/23/2011 9:19:38 AM
More...
|
Crimson Life Sciences Solves Japanese Translation Dilemma for U.S. Medical Device Manufacturers
5/2/2011 8:22:17 AM
More...
|
Crimson Life Sciences Release: Medical Device Risk Management Milestone: Industry's First 14971-Registered System Achieves Recertification
7/15/2010 12:53:02 PM
More...
|
Crimson Life Sciences Provides Online Resource for Medical Device Firms Seeking Reimbursement Guidance
6/22/2010 9:37:55 AM
More...
|
Crimson Life Sciences Introduces "Expert Opinion" Educational Webinar Series
5/27/2009 8:57:25 AM
More...
|
|